Recent advance in peripheral T-cell lymphoma, not otherwise specified.
- Author:
He-qin ZHAN
;
Xiao-qiu LI
;
Xiong-zeng ZHU
- Publication Type:Journal Article
- MeSH:
Alemtuzumab;
Antibodies, Monoclonal;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Antibodies, Neoplasm;
therapeutic use;
Antigens, CD;
metabolism;
Antigens, CD7;
metabolism;
Antigens, Neoplasm;
metabolism;
Antineoplastic Agents;
therapeutic use;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
CD3 Complex;
metabolism;
CD5 Antigens;
metabolism;
CD52 Antigen;
Chromosome Aberrations;
Chromosome Deletion;
Cyclophosphamide;
therapeutic use;
Diagnosis, Differential;
Doxorubicin;
therapeutic use;
Glycoproteins;
metabolism;
Hodgkin Disease;
metabolism;
pathology;
Humans;
Lymphoma, Large-Cell, Anaplastic;
metabolism;
pathology;
Lymphoma, T-Cell, Peripheral;
drug therapy;
genetics;
metabolism;
pathology;
Neoplasm Recurrence, Local;
Prednisone;
therapeutic use;
Receptors, CXCR3;
metabolism;
Survival Rate;
Vincristine;
therapeutic use
- From:
Chinese Journal of Pathology
2010;39(5):353-356
- CountryChina
- Language:Chinese
